Drug Delays Recurrence in People With Early-Stage Breast Cancer People who have inherited BRCA mutations and are at high risk for cancer recurrence may benefit from a PARP inhibitor. by Pamela Rafalow Grossman Moving Away From the Maximum Tolerated Dose The FDA recently expressed a new commitment to testing cancer drugs at lower doses, rather than defaulting to the highest dose most people can tolerate. by Marcus A. Banks Forward Look Going Flat Most people who opt out of breast reconstruction are satisfied with their decision but are not always supported by their surgeons. by Kris Conner Q&A Cancer, From the Other Side When Liza Marshall was diagnosed with stage III breast cancer, she and her husband, oncologist John Marshall, had to chart new waters. by Marci A. Landsmann Genetic Testing Gaps Testing for hereditary mutations is increasingly recommended for people with cancer, but recommendations do not always translate into access to testing and appropriate counseling. by Kate Yandell When Cancer’s Spread Is Limited People with cancer that has spread to only a few locations—called oligometastatic cancer—may benefit from aggressive local treatment. by Kate Yandell Immunotherapy Options for Breast Cancer Two immune checkpoint inhibitors are now approved for treatment of some people with advanced breast cancer, but trial results have raised some questions. by Anna Goshua Living Beyond a Diagnosis Judy Pearson was surprised by the demands of cancer survivorship. Here, she offers tips on how to look at life after cancer. by Judy Pearson Roadblocks to Care Some cancer patients struggle to find transportation to their appointments. The coronavirus pandemic has further limited options for patients looking for rides. by Anna Goshua Forward Look Doing More With Less Hypofractionation may allow patients to finish radiation treatment sooner. by Stephen Ornes next Cancer Talk An Emerging Treatment for Metastatic Prostate Cancer A drug that delivers radioactive particles to prostate cancer cells increases overall survival for metastatic castration-resistant prostate cancer. by Pamela Rafalow Grossman Exercise, Cancer and Aging A study on aging shows that cancer survivors are at higher risk of losing strength and walking more slowly compared to those with no cancer history. Exercise is one way to combat this decline. by Marcus A. Banks Preconceived Notions: Cancer, Fertility Coverage and the Law Insurance coverage for fertility treatments is not mandated by federal law, although some states require it. People seeking cancer treatment need to understand their coverage and the law in their state. by Shelly Rosenfeld Drug Delays Recurrence in People With Early-Stage Breast Cancer People who have inherited BRCA mutations and are at high risk for cancer recurrence may benefit from a PARP inhibitor. by Pamela Rafalow Grossman More Posts